Serum levels of high mobility group box 1 protein and its association with quality of life and psychological and functional status in patients with fibromyalgia

International Journal of Rheumatic Diseases

Volumn 16, Issue 4, 2013, Pages 403-407

  Oktayoglu, Pelin ^a   Tahtasiz, Mehmet ^a   Bozkurt, Mehtap ^a   Em, Serda ^a   Ucar, Demet ^a   Yazmalar, Levent ^a   Mete, Nuriye ^a   Nas, Kemal ^a   Gezer, Orhan ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Fibromyalgia; Functional status; High mobility group box 1 protein; Psychological status; Quality of life

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN;

ADULT; ANXIETY; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MALE; NOTTINGHAM HEALTH PROFILE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE;

FIBROMYALGIA; FUNCTIONAL STATUS; HIGH MOBILITY GROUP BOX 1 PROTEIN; PSYCHOLOGICAL STATUS; QUALITY OF LIFE;

ADULT; ANXIETY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DEPRESSION; DISABILITY EVALUATION; FEMALE; FIBROMYALGIA; HMGB1 PROTEIN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 84883464820     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12124     Document Type: Article

References (30)

1. Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH (2001) Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 40, 743-749.
2. Bianchi ME (2007) DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 81, 1-5.
3. Pisetsky DS, Erlandsson-Harris H, Andersson U (2008) High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther 10, 209.
4. Pöllänen R, Sillat T, Pajarinen J et al. (2009) Microbial antigens mediate HLA-B27 diseases via TLRs. J Autoimmun 32, 172-177.
5. Yu M, Wang H, Ding A et al. (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26, 174-179.
6. Park JS, Gamboni-Robertson F, He Q et al. (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290, 917-924.
7. Anderson U, Wang H, Palmblad K et al. (2000) High mobility group 1 protein (HMG 1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192, 565-570.
8. Jiang W, Pisetsky D (2006) The role of IFN alfa and Nitric Oxide in the Release of HMGB1 by RAW 264.7 Cells Stimulated with Polyinosinic-Polycytidylic Acid or Lipopolysaccharide. J Immunol 177, 3337-3343.
9. Wang H, Moser M, Schiltenwolf M, Buchner M (2008) Circulating cytokine levels compared to pain in patients with fibromyalgia. A prospective longitudinal study over 6 months. J Rheumatol 35, 1366-1370.
10. Bazzichi L, Rossi A, Massimetti G et al. (2007) Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 25, 225-230.
11. Larson A, Giovengo SL, Russell IJ, Michalek JE (2000) Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain 87, 201-211.
12. Akkus S, Nazi{dotless}roǧlu M, Eris S, Yalman K, Yi{dotless}lmaz N, Yener M (2009) Levels of lipid peroxidation, nitric oxide, and antioxidant vitamins in plasma of patients with fibromyalgia. Cell Biochem Funct 27, 181-185.
13. Tang D, Kang R, Zeh H, Lotze M (2011) High-Mobility Group Box 1, Oxidative Stress, and Disease. Antioxid Redox Signal 14, 1315-1335.
14. Wolfe F, Smythe HA, Yunus MB et al. (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 33, 160-172.
15. Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18, 728-733.
16. Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the fibromyalgia impact questionnaire. Rheumatol Int 20, 9-12.
17. Hunt SM, McKenna SP, McEwen J, Williams J, Papp E (1981) The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med A 15, 221-229.
18. Kucukdeveci AA, McKenna SP, Kutlay S, Gursel Y, Whalley D, Arasil T (2000) The development and psychometric assessment of the Turkish version of the Nottingham health profile. Int J Rehabil Res 23, 31-38.
19. Zigmond AS, Snaith PR (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67, 361-370.
20. Aydemir O, Guvenir T, Kuey L, Kultur S (1997) Validity and reliability of Turkish version of hospital anxiety and depression scale. Turk Psikiyatri Dergisi 8, 280-287.
21. Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yildizhan H (2006) Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int 26, 598-603.
22. Grundtman C, Bruton J, Yamada T et al. (2010) Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J 24, 570-578.
23. Taniguchi N, Kawahara K, Yone K et al. (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48, 971-981.
24. Ma CY, Jiao YL, Zhang J et al. (2012) Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus. Rheumatol Int 32, 395-402.
25. Ek M, Popovic K, Harris HE, Nauclér CS, Wahren-Herlenius M (2006) Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 54, 2289-2294.
26. Ahn JK, Cha HS, Bae EK, Lee J, Koh EM (2011) Extracellular high-mobility group box 1 is increased in patients with Behçet's disease with intestinal involvement. J Korean Med Sci 26, 697-700.
27. Koldas ŞD, Aytur YK, Atbaşoglu C (2011) Assessment of the relatives or spouses cohabiting with the fibromyalgia patients: is there a link regarding fibromyalgia symptoms, quality of life, general health and psychologic status? Rheumatol Int 31, 1137-1142.
28. Ulusoy H, Sari{dotless}ca N, Arslan S et al. (2010) Serum vitamin D status and bone mineral density in fibromyalgia. Bratisl Lek Listy 111, 604-609.
29. Gur A, Karakoc M, Erdogan S, Nas K, Cevik R, Sarac AJ (2002) Regional cerebral blood flow and cytokines in young females with fibromyalgia. Clin Exp Rheumatol 20, 753-760.
30. Gormsen L, Rosenberg R, Bach FW, Jensen TS (2010) Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. Eur J Pain 14, 127-128.